CN Stock MarketDetailed Quotes

688670 Jiangsu Gdk Biological Technology

Watchlist
  • 16.04
  • +0.39+2.49%
Market Closed Nov 12 15:00 CST
1.98BMarket Cap-17434P/E (TTM)

Jiangsu Gdk Biological Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-67.81%38.9M
-97.41%3.29M
-95.28%5.02M
-57.74%134.59M
-45.16%120.84M
675.48%127.14M
751.94%106.22M
-18.81%318.49M
-36.83%220.36M
-48.91%16.4M
Operating revenue
-67.81%38.9M
-97.41%3.29M
-95.28%5.02M
-57.74%134.59M
-45.16%120.84M
675.48%127.14M
751.94%106.22M
-18.81%318.49M
-36.83%220.36M
-48.91%16.4M
Total operating cost
-21.46%108.06M
-42.49%61.4M
-54.46%34.08M
-27.77%183.18M
-20.61%137.59M
102.77%106.76M
253.92%74.84M
-5.85%253.6M
-21.60%173.31M
-19.14%52.65M
Operating cost
-34.86%13.47M
-96.64%733.78K
-96.08%631.05K
-40.97%29.86M
-36.43%20.68M
1,102.88%21.83M
1,106.17%16.1M
-11.53%50.59M
-14.02%32.54M
-61.51%1.81M
Operating tax surcharges
51.72%2.08M
7.20%1.25M
-20.71%651.09K
-26.49%2.09M
-33.76%1.37M
92.83%1.16M
108.58%821.12K
-20.28%2.84M
-24.52%2.07M
-44.87%603.76K
Operating expense
-46.53%29.75M
-83.40%8.85M
-88.87%4.45M
-28.30%77.07M
-27.47%55.64M
648.33%53.32M
684.58%40.01M
-7.55%107.49M
-33.48%76.7M
-40.00%7.13M
Administration expense
-5.91%46.77M
57.68%37.64M
69.97%25.14M
-3.27%58.64M
32.03%49.71M
-5.30%23.87M
26.69%14.79M
21.32%60.62M
31.16%37.65M
24.87%25.21M
Financial expense
116.13%300.57K
4.88%135.16K
-58.97%6.54K
112.09%42.98K
-267.85%-1.86M
124.98%128.87K
105.19%15.94K
-104.99%-355.53K
-106.67%-506.69K
-107.67%-515.98K
-Interest expense (Financial expense)
-11.18%1.23M
7.52%895.24K
2.00%436.87K
48.11%1.9M
66.08%1.38M
93.37%832.65K
157.62%428.3K
-87.00%1.28M
-91.52%831.06K
-94.11%430.59K
-Interest Income (Financial expense)
71.64%-934.95K
-1.86%-766.51K
-3.94%-433.7K
-14.35%-1.9M
-157.38%-3.3M
21.93%-752.47K
12.65%-417.28K
39.57%-1.66M
-56.59%-1.28M
-64.12%-963.89K
Research and development
30.17%15.68M
98.40%12.79M
3.23%3.2M
-52.26%15.47M
-51.53%12.05M
-64.99%6.45M
5.11%3.1M
-8.08%32.41M
-13.86%24.86M
-10.20%18.42M
Credit Impairment Loss
-94.11%783.01K
-79.59%1.71M
36.90%-393.28K
1,080.35%11.27M
5,232.31%13.28M
-24.67%8.36M
-117.44%-623.3K
8.90%-1.15M
109.91%249.1K
-2.74%11.1M
Asset Impairment Loss
78.05%-5.39M
-101.49%-81.8K
-101.21%-68.69K
-45.18%-55.68M
-849.18%-24.53M
3,612.39%5.48M
4,916.29%5.69M
33.81%-38.35M
80.11%-2.58M
98.44%-155.92K
Other net revenue
Fair value change income
4,380.42%96.66K
-125.85%-160.78K
-490.10%-278.54K
91.57%-146.86K
100.26%2.16K
-64.47%621.98K
-91.69%71.4K
-175.39%-1.74M
---826.69K
--1.75M
Invest income
33.86%9.68M
70.04%7.49M
6.04%3.66M
-16.55%13.25M
-35.88%7.23M
-29.99%4.4M
-10.57%3.45M
220.92%15.87M
1,071.91%11.28M
1,121.90%6.29M
Asset deal income
--8.66K
--8.66K
--8.66K
----
----
----
----
597.11%232.45K
----
----
Other revenue
-81.31%755.86K
-64.52%529.33K
-75.94%305.2K
-43.28%5.21M
-43.80%4.04M
-71.74%1.49M
460.07%1.27M
-29.60%9.19M
-1.62%7.19M
34.90%5.28M
Operating profit
-278.35%-63.22M
-219.35%-48.62M
-162.65%-25.84M
-252.62%-74.69M
-126.79%-16.71M
439.78%40.74M
14,772.22%41.24M
-41.72%48.94M
-48.26%62.36M
55.91%-11.99M
Add:Non operating Income
172.12%47.66K
154.60%30.02K
-23.52%3.17K
112.15%72.73K
-47.21%17.51K
-41.28%11.79K
-61.17%4.14K
-8.66%34.28K
48.97%33.18K
96.22%20.08K
Less:Non operating expense
-16.72%519.13K
-84.83%94.54K
----
2,020.62%11.96M
665.73%623.33K
--623.33K
--495.1K
17,618.63%563.88K
--81.4K
----
Total profit
-267.84%-63.69M
-221.33%-48.68M
-163.39%-25.83M
-278.84%-86.57M
-127.79%-17.32M
435.24%40.12M
15,168.98%40.75M
-42.37%48.41M
-48.31%62.31M
55.97%-11.97M
Less:Income tax cost
-64.00%-10.23M
-255.00%-7.82M
-198.62%-4.34M
-327.01%-15.58M
-193.15%-6.24M
-4.64%5.04M
85.67%4.4M
345.53%6.86M
-67.30%6.7M
236.42%5.29M
Net profit
FPtoL-53.46M
SL-40.87M
SL-21.49M
SL-70.99M
SL-11.08M
FLtoP35.08M
FLtoP36.35M
-49.62%41.54M
-44.43%55.62M
FPtoL-17.26M
Net profit from continuing operation
-382.63%-53.46M
-216.49%-40.87M
-159.13%-21.49M
-270.88%-70.99M
-119.92%-11.08M
303.27%35.08M
1,475.84%36.35M
-49.62%41.54M
-44.43%55.62M
25.95%-17.26M
Net profit of parent company owners
-382.63%-53.46M
-216.49%-40.87M
-159.13%-21.49M
-270.88%-70.99M
-119.92%-11.08M
303.27%35.08M
1,475.84%36.35M
-49.62%41.54M
-44.43%55.62M
25.95%-17.26M
Earning per share
Basic earning per share
-377.78%-0.43
-217.86%-0.33
-156.67%-0.17
-270.59%-0.58
-120.00%-0.09
300.00%0.28
1,100.00%0.3
-69.09%0.34
-68.09%0.45
60.00%-0.14
Diluted earning per share
-377.78%-0.43
-217.86%-0.33
-156.67%-0.17
-270.59%-0.58
-120.00%-0.09
300.00%0.28
1,100.00%0.3
-69.09%0.34
-68.09%0.45
60.00%-0.14
Other composite income
Total composite income
-382.63%-53.46M
-216.49%-40.87M
-159.13%-21.49M
-270.88%-70.99M
-119.92%-11.08M
303.27%35.08M
1,475.84%36.35M
-49.62%41.54M
-44.43%55.62M
25.95%-17.26M
Total composite income of parent company owners
-382.63%-53.46M
-216.49%-40.87M
-159.13%-21.49M
-270.88%-70.99M
-119.92%-11.08M
303.27%35.08M
1,475.84%36.35M
-49.62%41.54M
-44.43%55.62M
25.95%-17.26M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -67.81%38.9M-97.41%3.29M-95.28%5.02M-57.74%134.59M-45.16%120.84M675.48%127.14M751.94%106.22M-18.81%318.49M-36.83%220.36M-48.91%16.4M
Operating revenue -67.81%38.9M-97.41%3.29M-95.28%5.02M-57.74%134.59M-45.16%120.84M675.48%127.14M751.94%106.22M-18.81%318.49M-36.83%220.36M-48.91%16.4M
Total operating cost -21.46%108.06M-42.49%61.4M-54.46%34.08M-27.77%183.18M-20.61%137.59M102.77%106.76M253.92%74.84M-5.85%253.6M-21.60%173.31M-19.14%52.65M
Operating cost -34.86%13.47M-96.64%733.78K-96.08%631.05K-40.97%29.86M-36.43%20.68M1,102.88%21.83M1,106.17%16.1M-11.53%50.59M-14.02%32.54M-61.51%1.81M
Operating tax surcharges 51.72%2.08M7.20%1.25M-20.71%651.09K-26.49%2.09M-33.76%1.37M92.83%1.16M108.58%821.12K-20.28%2.84M-24.52%2.07M-44.87%603.76K
Operating expense -46.53%29.75M-83.40%8.85M-88.87%4.45M-28.30%77.07M-27.47%55.64M648.33%53.32M684.58%40.01M-7.55%107.49M-33.48%76.7M-40.00%7.13M
Administration expense -5.91%46.77M57.68%37.64M69.97%25.14M-3.27%58.64M32.03%49.71M-5.30%23.87M26.69%14.79M21.32%60.62M31.16%37.65M24.87%25.21M
Financial expense 116.13%300.57K4.88%135.16K-58.97%6.54K112.09%42.98K-267.85%-1.86M124.98%128.87K105.19%15.94K-104.99%-355.53K-106.67%-506.69K-107.67%-515.98K
-Interest expense (Financial expense) -11.18%1.23M7.52%895.24K2.00%436.87K48.11%1.9M66.08%1.38M93.37%832.65K157.62%428.3K-87.00%1.28M-91.52%831.06K-94.11%430.59K
-Interest Income (Financial expense) 71.64%-934.95K-1.86%-766.51K-3.94%-433.7K-14.35%-1.9M-157.38%-3.3M21.93%-752.47K12.65%-417.28K39.57%-1.66M-56.59%-1.28M-64.12%-963.89K
Research and development 30.17%15.68M98.40%12.79M3.23%3.2M-52.26%15.47M-51.53%12.05M-64.99%6.45M5.11%3.1M-8.08%32.41M-13.86%24.86M-10.20%18.42M
Credit Impairment Loss -94.11%783.01K-79.59%1.71M36.90%-393.28K1,080.35%11.27M5,232.31%13.28M-24.67%8.36M-117.44%-623.3K8.90%-1.15M109.91%249.1K-2.74%11.1M
Asset Impairment Loss 78.05%-5.39M-101.49%-81.8K-101.21%-68.69K-45.18%-55.68M-849.18%-24.53M3,612.39%5.48M4,916.29%5.69M33.81%-38.35M80.11%-2.58M98.44%-155.92K
Other net revenue
Fair value change income 4,380.42%96.66K-125.85%-160.78K-490.10%-278.54K91.57%-146.86K100.26%2.16K-64.47%621.98K-91.69%71.4K-175.39%-1.74M---826.69K--1.75M
Invest income 33.86%9.68M70.04%7.49M6.04%3.66M-16.55%13.25M-35.88%7.23M-29.99%4.4M-10.57%3.45M220.92%15.87M1,071.91%11.28M1,121.90%6.29M
Asset deal income --8.66K--8.66K--8.66K----------------597.11%232.45K--------
Other revenue -81.31%755.86K-64.52%529.33K-75.94%305.2K-43.28%5.21M-43.80%4.04M-71.74%1.49M460.07%1.27M-29.60%9.19M-1.62%7.19M34.90%5.28M
Operating profit -278.35%-63.22M-219.35%-48.62M-162.65%-25.84M-252.62%-74.69M-126.79%-16.71M439.78%40.74M14,772.22%41.24M-41.72%48.94M-48.26%62.36M55.91%-11.99M
Add:Non operating Income 172.12%47.66K154.60%30.02K-23.52%3.17K112.15%72.73K-47.21%17.51K-41.28%11.79K-61.17%4.14K-8.66%34.28K48.97%33.18K96.22%20.08K
Less:Non operating expense -16.72%519.13K-84.83%94.54K----2,020.62%11.96M665.73%623.33K--623.33K--495.1K17,618.63%563.88K--81.4K----
Total profit -267.84%-63.69M-221.33%-48.68M-163.39%-25.83M-278.84%-86.57M-127.79%-17.32M435.24%40.12M15,168.98%40.75M-42.37%48.41M-48.31%62.31M55.97%-11.97M
Less:Income tax cost -64.00%-10.23M-255.00%-7.82M-198.62%-4.34M-327.01%-15.58M-193.15%-6.24M-4.64%5.04M85.67%4.4M345.53%6.86M-67.30%6.7M236.42%5.29M
Net profit FPtoL-53.46MSL-40.87MSL-21.49MSL-70.99MSL-11.08MFLtoP35.08MFLtoP36.35M-49.62%41.54M-44.43%55.62MFPtoL-17.26M
Net profit from continuing operation -382.63%-53.46M-216.49%-40.87M-159.13%-21.49M-270.88%-70.99M-119.92%-11.08M303.27%35.08M1,475.84%36.35M-49.62%41.54M-44.43%55.62M25.95%-17.26M
Net profit of parent company owners -382.63%-53.46M-216.49%-40.87M-159.13%-21.49M-270.88%-70.99M-119.92%-11.08M303.27%35.08M1,475.84%36.35M-49.62%41.54M-44.43%55.62M25.95%-17.26M
Earning per share
Basic earning per share -377.78%-0.43-217.86%-0.33-156.67%-0.17-270.59%-0.58-120.00%-0.09300.00%0.281,100.00%0.3-69.09%0.34-68.09%0.4560.00%-0.14
Diluted earning per share -377.78%-0.43-217.86%-0.33-156.67%-0.17-270.59%-0.58-120.00%-0.09300.00%0.281,100.00%0.3-69.09%0.34-68.09%0.4560.00%-0.14
Other composite income
Total composite income -382.63%-53.46M-216.49%-40.87M-159.13%-21.49M-270.88%-70.99M-119.92%-11.08M303.27%35.08M1,475.84%36.35M-49.62%41.54M-44.43%55.62M25.95%-17.26M
Total composite income of parent company owners -382.63%-53.46M-216.49%-40.87M-159.13%-21.49M-270.88%-70.99M-119.92%-11.08M303.27%35.08M1,475.84%36.35M-49.62%41.54M-44.43%55.62M25.95%-17.26M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data